1. Personalizing Therapy for Colorectal Cancer
Ashley Wong, Brigette B.Y. Ma 
Clinical Gastroenterology and Hepatology 
Volume 12, Issue 1, Pages (January 2014)
DOI: /j.cgh
Copyright © 2014 AGA Institute Terms and Conditions

2. Figure 1
Selected signaling pathways of clinical significance in CRC and therapeutic targets. Schematic diagram of approved targeted agents for treatment of advanced CRC and their mode of action in a CRC cell. AKT, protein kinase B; BAD, Bcl-2-associated death promoter; MAPK, mitogen-activated protein kinase; mTOR, mammalian target of rapamycin; NFκB, nuclear factor κ-light-chain-enhancer of activated B cells; PIGF, phosphatidylinositol-glycan biosynthesis class F protein.
Clinical Gastroenterology and Hepatology  , DOI: ( /j.cgh )
Copyright © 2014 AGA Institute Terms and Conditions